EU Says Drugmakers Blocked Cheaper Drugs (TheStreet.com)

European patients had to pay about $3.87 billion more for medicines in 2000-2007 because drugmakers stalled the sale of cheaper generic versions, EU antitrust regulators said.

More: continued here

This entry was posted on Friday, November 28th, 2008 at 5:11 am and is filed under Stock-Picks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.